Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging
Nicholas E. Propson, Ethan R. Roy, Alexandra Litvinchuk, Jörg Köhl, Hui Zheng
Nicholas E. Propson, Ethan R. Roy, Alexandra Litvinchuk, Jörg Köhl, Hui Zheng
View: Text | PDF
Research Article Aging

Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging

  • Text
  • PDF
Abstract

Dysfunction of immune and vascular systems has been implicated in aging and Alzheimer disease; however, their interrelatedness remains poorly understood. The complement pathway is a well-established regulator of innate immunity in the brain. Here, we report robust age-dependent increases in vascular inflammation, peripheral lymphocyte infiltration, and blood-brain barrier (BBB) permeability. These phenotypes were subdued by global inactivation and by endothelial cell–specific ablation of C3ar1. Using an in vitro model of the BBB, we identified intracellular Ca2+ as a downstream effector of C3a/C3aR signaling and a functional mediator of vascular endothelial cadherin junction and barrier integrity. Endothelial C3ar1 inactivation also dampened microglia reactivity and improved hippocampal and cortical volumes in the aging brain, demonstrating a crosstalk between brain vasculature dysfunction and immune cell activation and neurodegeneration. Further, prominent C3aR-dependent vascular inflammation was also observed in a tau-transgenic mouse model. Our studies suggest that heightened C3a/C3aR signaling through endothelial cells promotes vascular inflammation and BBB dysfunction and contributes to overall neuroinflammation in aging and neurodegenerative disease.

Authors

Nicholas E. Propson, Ethan R. Roy, Alexandra Litvinchuk, Jörg Köhl, Hui Zheng

×

Figure 3

CD8+ T cells are preferentially recruited and infiltrate the aged brain.

Options: View larger image (or click on image) Download as PowerPoint
CD8+ T cells are preferentially recruited and infiltrate the aged brain....
(A) Schematic for flow cytometry analysis of dissociated infiltrating cells in the 20-month-old brain or spleen using antibody staining against CD45, CD11b, CD3ε, CD19, CD8a, and CD4. TC, T cells; BC, B cells. (B) Quantification of flow cytometry analysis showed predominantly CD3+ T cells in the brain compared with the spleen, which showed predominantly CD19+ B cells (n = 7/group). (C) Quantification of T cells showed the predominant subtype enriched in the brain was CD8+ T cells compared with CD4+ T cells in the spleen (n = 7/group). (D) Representative immunostaining of 2-month-old and 20-month-old brain tissue using anti-CD8a and anti–Col IV to determine regional immune cell infiltration within the brain. (E) Magnified image from D highlighting the infiltrated cell types that were counted for analysis. (F) Quantification of regional distribution of CD8+ T cell infiltrates in 4 major brain regions (n = 4/group, 2 tissue sections per mouse). CTX, cortex; THAL, thalamus; CPu, caudate putamen; HPC,hippocampus. (G) Representative images of 3 distinct stages of infiltration observed in all brain regions: perivascular residence (left panel), extravasation (middle panel), and parenchymal surveillance (right panel). Data in B and C represent the mean ± SEM. Analysis was done using 1-way ANOVA with Tukey’s post hoc test (***P < 0.001). Data in F are violin plots displaying medians and quartile ranges. Analysis was done using 2-way ANOVA with Holm-Sidak post hoc test (*P < 0.05, ***P < 0.001). Scale bars: 100 μm (D), 50 μm (E), 10 μm (G).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts